Intercept falls after REVERSE study misses its primary endpoint Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Voya Financial (VOYA) up 1% after Piper Sandler upgraded the stock to Overweight
- Generac (GNRC) up 2% after Cowen initiated coverage of shares with an Outperform rating and $229 price target
UP AFTER EARNINGS -
DOWN AFTER EARNINGS -
- Nike (NKE) up 12%
- Micron (MU) down 1%
LOWER -
- Intercept (ICPT) down 15% after announcing that its REVERSE study evaluating the safety and efficacy of OCA in patients with compensated cirrhosis due to nonalcoholic steatohepatitis did not meet its primary endpoint
- Amylyx (AMLX) down 2% after announcing that the FDA has approved Relyvrio for the treatment of adults with amyotrophic lateral sclerosis
- Rent-A-Center (RCII) down 14% after after cutting Q3 earnings guidance
Symbols:
VOYA AMLX GNRC CMTL MU NKE RCII ICPT Keywords: Fly Intel, Wall Street, Top Stories, Stocks